NEW YORK, Nov. 17, 2014 /PRNewswire-USNewswire/ -- The Cannabinoid Research Group of Complutense University in Madrid, Spain and Voices Against Brain Cancer, a national foundation headquartered in New York, announce today that a collaborative alliance has been signed by both organizations. The consideration of the benefits of Marijuana and the compounds contained within the plant known as "cannabinoids" for medicinal purposes is currently a prominent subject matter in North America. In an effort to fast track the propagation of accurate scientific based information on therapeutic opportunities incorporating cannabinoids, these two groups have formed an exclusive partnership in the United States.
"We have chosen Voices Against Brain Cancer to act as our voice in North America where they will support and herald our efforts," stated Manuel Guzmán, Chairman of The Cannabinoid Research Group. When asked about the research findings to date, Mr. Guzman noted that "published research clearly shows the anticancer action of cannabinoids impacting glioblastoma multiforma (GBM), and how chemotherapy results of tumor reduction are improved upon by adding cannabinoids as part of the treatment regimen."
"We have an obligation to remain open minded about where the cure for brain cancer will come from, said Michael Klipper, Chairman of Voices Against Brain Cancer. Manuel Guzmán and his research team are world class leaders in the clinical research of cannabinoids and cancer." We recognize our responsibility to disseminate the information associated with the published research, which supports the medicinal legitimacy and can help guide patients and government lawmakers when considering the use of Cannabinoids."
About Voices Against Brain Cancer
Voices Against Brain Cancer's mission is to find a cure for brain cancer and brain tumors by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
Voices Against Brain Cancer has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization's research grants fund cutting-edge programs that will have a monumental impact on the diagnosis and treatment of brain cancer. Currently, these grants are being funded at numerous esteemed institutions including: Baylor University, Boston Children's Hospital / Harvard, Brookhaven National Laboratory, Central Brain Tumor Registry Of The United States, Children's Hospital Of Philadelphia, Cleveland Clinic, Columbia, Cornell, Dana Farber / Harvard, Duke, The Feinstein Institute / North Shore LIJ Health System, Harvard, Hofstra / North Shore LIJ School Of Medicine, Johns Hopkins, Lenox Hill Hospital / North Shore LIJ Health System, Lurie Children's Hospital / Northwestern, Massachusetts General Hospital / Harvard, MD Anderson, Memorial Sloan Kettering, New York University, Ohio State University, Rush University, Stony Brook University, UC Davis, UC Irvine, UCLA, UCSD, UCSF, University of Chicago, University of Michigan, University Of Pittsburgh, University Of Virginia, Vanderbilt University, Wake Forest, Washington University, Yale and more. VABC continues to hold events across the country in locations such as Boston, Chicago, Connecticut, Dallas, Long Island-New York, Los Angeles, Miami, New Orleans, New York City, Phoenix, Salt Lake City, San Francisco and Washington, DC. www.voicesagainstbraincancer.org
About The Cannabinoid Research Group
The Cannabinoid Signaling (Research) Group belongs to the Department of Biochemistry and Molecular Biology I at the Schools of Chemistry and Biology, Complutense University, Madrid, Spain. The group is Chaired by Manuel Guzmán, with three lines of ongoing research co-chaired by Ismael Galve-Roperh, Cristina Sánchez and Guillermo Velasco.
Currently, the major focus of our group is the study of the mechanisms by which cannabinoids – the active components of Cannabis sativa L. – and their endogenous counterparts control the proliferation, differentiation and survival of different types of cells.
For press inquiries, please contact: 5W Public Relations.
SOURCE Voices Against Brain Cancer